Literature DB >> 20635475

Application of PAMPA-models to predict BBB permeability including efflux ratio, plasma protein binding and physicochemical parameters.

Jurgen Mensch1, Libuse Jaroskova, Wendy Sanderson, Anouche Melis, Claire Mackie, Geert Verreck, Marcus E Brewster, Patrick Augustijns.   

Abstract

This study examines whether algorithms to predict brain penetration of 88 drug candidates could benefit from inclusion of PAMPA data such as Peff, flux and membrane retention. Specifically the ability to fit experimentally derived LogBB data with PAMPA information and compound related physicochemical and structural parameters was assessed. Collected data were analyzed by partial least square analysis and various regression models for LogBB. Four PAMPA methodologies were evaluated in this study including: (1) a PAMPA-BLM (black lipid membrane) model, (2) a PAMPA-DS (double sink) model, (3) a PAMPA-BBB (blood-brain barrier) model and (4) a PAMPA-BBB-UWL (unstirred water layer). Additionally, plasma protein binding (PPB) experiments and a Caco-2 assay were performed to determine the unbound fraction in plasma and the efflux ratio, respectively, for subsets of the selected compounds. This information was combined with the obtained PAMPA data in an effort to improve the predictions of LogBB. Taken in aggregate, the results presented, suggest that the PAMPA-BLM parameters are the most important contributors to predict the LogBB. The optimized multiple linear regression (MLR) relationship including the PAMPA-BLM properties demonstrated a slightly improved prediction compared to the model without the PAMPA-BLM parameters. Including the plasma protein binding of 15 compounds resulted in a significantly improved PAMPA-BLM prediction of LogBB, while integrating the efflux ratio with PAMPA-BLM or PAMPA-BBB Peff values, resulted in improved classification of brain permeable [BBB + (LogBB >or= 0)] and impermeable [BBB--(LogBB < 0)] compounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20635475

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationship.

Authors:  Euitae Kim; Oliver D Howes; Bo-Hyung Kim; Jae Min Jeong; Jae Sung Lee; In-Jin Jang; Sang-Goo Shin; Federico E Turkheimer; Shitij Kapur; Jun Soo Kwon
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-21       Impact factor: 6.200

Review 2.  Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain.

Authors:  Yi Zheng; Xijing Chen; Leslie Z Benet
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

Review 3.  In vitro blood-brain barrier models: current and perspective technologies.

Authors:  Pooja Naik; Luca Cucullo
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

4.  Qualitative prediction of blood-brain barrier permeability on a large and refined dataset.

Authors:  Markus Muehlbacher; Gudrun M Spitzer; Klaus R Liedl; Johannes Kornhuber
Journal:  J Comput Aided Mol Des       Date:  2011-11-23       Impact factor: 3.686

Review 5.  Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.

Authors:  Noora Sjöstedt; Hanna Kortejärvi; Heidi Kidron; Kati-Sisko Vellonen; Arto Urtti; Marjo Yliperttula
Journal:  Pharm Res       Date:  2014-01       Impact factor: 4.200

6.  Developing Enhanced Blood-Brain Barrier Permeability Models: Integrating External Bio-Assay Data in QSAR Modeling.

Authors:  Wenyi Wang; Marlene T Kim; Alexander Sedykh; Hao Zhu
Journal:  Pharm Res       Date:  2015-04-11       Impact factor: 4.200

Review 7.  In vitro cerebrovascular modeling in the 21st century: current and prospective technologies.

Authors:  Christopher A Palmiotti; Shikha Prasad; Pooja Naik; Kaisar M D Abul; Ravi K Sajja; Anilkumar H Achyuta; Luca Cucullo
Journal:  Pharm Res       Date:  2014-08-07       Impact factor: 4.200

8.  Significance of lipid composition in a blood-brain barrier-mimetic PAMPA assay.

Authors:  Scott D Campbell; Karen J Regina; Evan D Kharasch
Journal:  J Biomol Screen       Date:  2013-08-14

9.  Pyrazole antagonists of the CB1 receptor with reduced brain penetration.

Authors:  Alan Fulp; Yanan Zhang; Katherine Bortoff; Herbert Seltzman; Rodney Snyder; Robert Wiethe; George Amato; Rangan Maitra
Journal:  Bioorg Med Chem       Date:  2016-01-18       Impact factor: 3.641

10.  A new PAMPA model proposed on the basis of a synthetic phospholipid membrane.

Authors:  Hui Yu; Qi Wang; Ying Sun; Ming Shen; He Li; Yourong Duan
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.